Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to compare the effectiveness and safety of ABP 215 against bevacizumab in men and women with advanced non-small cell lung cancer.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Amgen
Collaborators
NCT07144280 · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, and more
NCT07250477 · Non-small Cell Lung Cancer Stage IIIC, Non-small Cell Lung Cancer Stage IV, and more
NCT02622581 · Metastatic Non-small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer Metastatic, and more
NCT06517953 · Non-small Cell Lung Cancer Metastatic, EGFR G719X, and more
NCT04563338 · Hepatocellular Carcinoma, Non-small Cell Lung Cancer Metastatic, and more
Research Site
Bismarck, North Dakota
Research Site
Fremantle, Western Australia
Research Site
Veliko Tarnovo, Veliko Tarnovo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions